Envestnet Asset Management Inc. lowered its holdings in shares of Certara, Inc. (NASDAQ:CERT – Free Report) by 43.8% during the 2nd quarter, HoldingsChannel reports. The fund owned 230,824 shares of the company’s stock after selling 179,863 shares during the period. Envestnet Asset Management Inc.’s holdings in Certara were worth $4,203,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of CERT. BlackRock Inc. boosted its stake in Certara by 157.8% during the first quarter. BlackRock Inc. now owns 14,796,486 shares of the company’s stock worth $356,743,000 after acquiring an additional 9,055,874 shares in the last quarter. State Street Corp boosted its stake in Certara by 92.2% during the first quarter. State Street Corp now owns 3,224,252 shares of the company’s stock worth $77,737,000 after acquiring an additional 1,546,396 shares in the last quarter. Clearbridge Investments LLC boosted its stake in Certara by 58.7% during the first quarter. Clearbridge Investments LLC now owns 3,200,895 shares of the company’s stock worth $68,755,000 after acquiring an additional 1,183,859 shares in the last quarter. Geneva Capital Management LLC boosted its stake in Certara by 55.6% during the second quarter. Geneva Capital Management LLC now owns 2,993,552 shares of the company’s stock worth $54,513,000 after acquiring an additional 1,069,340 shares in the last quarter. Finally, Norges Bank purchased a new position in Certara in the fourth quarter worth about $15,915,000. Institutional investors own 67.26% of the company’s stock.
Insider Buying and Selling at Certara
In other Certara news, insider Leif E. Pedersen sold 51,224 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $14.60, for a total transaction of $747,870.40. Following the completion of the sale, the insider now directly owns 128,883 shares of the company’s stock, valued at $1,881,691.80. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 2.60% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Certara Stock Up 0.7 %
CERT opened at $14.71 on Tuesday. The company has a quick ratio of 3.51, a current ratio of 3.51 and a debt-to-equity ratio of 0.27. The firm has a 50 day moving average price of $13.73 and a 200-day moving average price of $16.78. Certara, Inc. has a twelve month low of $11.81 and a twelve month high of $24.96. The stock has a market capitalization of $2.35 billion, a price-to-earnings ratio of -70.05, a PEG ratio of 1.15 and a beta of 1.51.
Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.
- Five stocks we like better than Certara
- What is a Special Dividend?
- The most upgraded stocks in November have two things in common
- How to Evaluate a Stock Before Buying
- Monday.com rocked earnings like it’s the weekend
- There Are Different Types of Stock To Invest In
- Plan to own one retailer? Make it this one
Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.